Complex Seal Oil
Natural health product licensed in Canada
- Licence holder
- Ideal Health Inc
- NPN or DIN-HM
- 80053624
- Status
- Active licence
- Licence date
- 5 September 2014
- Revision date
- Not provided
- Form
- Capsule, molle
- Route of administration
- Orale
- Application type
- Non traditionnelle
If this product were sold in France
- Conditions légales
Ginkgo biloba L.: L'étiquetage des compléments alimentaires qui contiennent la feuille de la plante Ginkgo biloba L. doit comporter un avertissement avec la teneur suivante: "Consultez votre médecin en cas de prise simultanée d'anticoagulants."
arrêté du 24 juin 2014, annexe I. French orders of 9 May 2006 (nutrients), 24 June 2014 (plants) and 26 September 2016 (other substances), consolidated LEGI collection, retrieved 23 October 2026.
A daily quantity is calculated only for an explicit adult oral dosage, stated per day and in a solid unit matching the product form. Ambiguous units, liquids, powders and paediatric doses are not extrapolated. A quantity not calculated is not compared with dose limits. This analysis does not constitute authorisation for sale in France or an assessment of safety or efficacy.
Composition
| Medicinal ingredient and source | Per dosage unit, according to the source | Maximum per day, adult |
|---|---|---|
| Huile de phoque Source : Pagophilus groenlandicus - petit lard Potency : 23.5 mg Docosapentaenoic acid | 500 mg | Not calculated |
| Huile de phoque Source : Pagophilus groenlandicus - petit lard Potency : 44.5 mg Docosahexaenoic acid | Not specified | Not calculated |
| Huile de phoque Source : Pagophilus groenlandicus - petit lard Potency : 38 mg Eicosapentaenoic acid | Not specified | Not calculated |
| 2,6,10,15,19,23-hexaméthyl-2,6,10,14,18,22-tétracosahexaène, (totalement E)- Source : Squalene | 12.5 mcg | Not calculated |
| Ginkgo biloba Source : Ginkgo biloba - feuille Extraction ratio : 4:1 Dry plant equivalent : 80 mg | 20 mg | Not calculated |
| Allium sativum Source : Allium sativum - Bulbe | 20 mg | Not calculated |
| 2,5-Cyclohexadiène-1,4-dione, 2-[(2E,6E,10E,14E,18E,22E,26E,30E,34E)-3,7,11,15,19,23,27,31,35,39-décaméthyl-2,6,10,14,18,22,26,30,34,38-tétracontadécaényl]-5,6-diméthoxy-3-méthyl Source : Coenzyme Q10 | 2.5 mg | Not calculated |
| Vitamine E Source : d-alpha tocophérol | 10.05 AT | Not calculated |
| Vitamine E Source : d-alpha tocophérol | 15 UI | Not calculated |
Non-medicinal ingredients
Gélatine, Cire d'abeille, Lécithine, Glycérine, Caramel, Eau purifiée
Recommended doses in Canada
| Population | Age | Quantity per serving | Frequency |
|---|---|---|---|
| Adultes | Not specified | 1 Capsule | minimum: 2 Tous les jours ; maximum: 3 Tous les jours |
Uses authorised in Canada
Text supplied in English because no French text is available.
Source of omega-3 fatty acids. Source of eicosapentaenoic acid (EPA), docosahexaenoic acid (DHA) and docosapentaenoic acid (DPA). A factor in the maintenance of good health.
A use authorised in Canada is not an authorised health claim in the European Union. See the health claims register.
Warnings in Canada
No French warning text available in the imported data.
Warnings are available in English on the official record.
Source
Official Health Canada record, licence 80053624
Licensed Natural Health Products Database (LNHPD), Health Canada: licensed products, ingredients, doses, uses and risks, retrieved 27 October 2026.
Contains information licensed under the Open Government Licence – Canada (Health Canada, LNHPD)
Licence du gouvernement ouvert – Canada 2.0 (OGL-Canada 2.0)
The formula sold in Europe under the same name may differ. This information does not replace advice from a doctor or pharmacist.
The evidence date of this ingredient list is unknown.
Has the product changed? Photograph the packaging.